Phreesia (NYSE:PHR) Price Target Cut to $19.00 by Analysts at Mizuho

Phreesia (NYSE:PHR) had its price target decreased by Mizuho from $22.00 to $19.00 in a report released on Tuesday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock.

Other research analysts have also recently issued reports about the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research report on Wednesday, January 28th. Wells Fargo & Company began coverage on shares of Phreesia in a research note on Thursday, January 8th. They issued an “overweight” rating and a $30.00 target price on the stock. Barclays decreased their price target on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating for the company in a research report on Tuesday, December 16th. Canaccord Genuity Group cut their price objective on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a research report on Tuesday, December 9th. Finally, Zacks Research cut Phreesia from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. Seventeen investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.94.

Phreesia Stock Performance

NYSE PHR opened at $11.29 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. Phreesia has a 1-year low of $10.75 and a 1-year high of $32.76. The firm has a market capitalization of $680.37 million, a P/E ratio of -112.84 and a beta of 0.67. The business’s 50-day simple moving average is $12.91 and its 200-day simple moving average is $18.10.

Insider Buying and Selling at Phreesia

In related news, insider David Linetsky sold 6,038 shares of Phreesia stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $98,781.68. Following the sale, the insider owned 223,942 shares of the company’s stock, valued at $3,663,691.12. The trade was a 2.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Balaji Gandhi sold 4,687 shares of the business’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $76,679.32. Following the completion of the transaction, the chief financial officer owned 150,569 shares in the company, valued at $2,463,308.84. This represents a 3.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 60,353 shares of company stock worth $1,006,528. 5.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PHR. Vanguard Group Inc. increased its holdings in Phreesia by 8.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock worth $134,177,000 after purchasing an additional 437,462 shares during the last quarter. New York State Common Retirement Fund raised its position in shares of Phreesia by 727.1% in the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after purchasing an additional 120,309 shares in the last quarter. Squarepoint Ops LLC boosted its stake in shares of Phreesia by 243.6% during the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after buying an additional 71,553 shares during the last quarter. Greenhouse Funds LLLP boosted its stake in shares of Phreesia by 16.8% during the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after buying an additional 557,265 shares during the last quarter. Finally, Bessemer Group Inc. grew its position in shares of Phreesia by 1,065.9% during the third quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock worth $13,043,000 after buying an additional 506,954 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.